Published in Int J Clin Exp Pathol on August 15, 2014
Therapeutic potential of α-crystallin. Biochim Biophys Acta (2015) 0.77
αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic target. Pharmacol Ther (2016) 0.76
Differential phosphorylation-based regulation of αB-crystallin chaperone activity for multipass transmembrane proteins. Biochem Biophys Res Commun (2016) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature (2007) 3.92
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest (2006) 2.74
Can metastatic colorectal cancer be cured? Oncology (Williston Park) (2012) 2.32
alphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood (2009) 2.10
ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance. Urol Oncol (2012) 1.56
Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey. World J Gastroenterol (2010) 1.29
Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagn Pathol (2013) 1.11
Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma. Hum Pathol (2008) 1.09
Increased ZO-1 expression predicts valuable prognosis in non-small cell lung cancer. Int J Clin Exp Pathol (2013) 1.07
Chaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataracts. J Biol Chem (2013) 1.05
Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. J Exp Clin Cancer Res (2012) 1.05
MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol Cancer (2014) 1.03
αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res (2013) 1.02
Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies. PLoS One (2014) 1.00
Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int J Clin Exp Pathol (2014) 0.97
αB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells. Mol Cancer Res (2011) 0.95
High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma. Int J Clin Exp Pathol (2013) 0.93
Increased alpha-B-crystallin expression in mammary metaplastic carcinomas. Histopathology (2011) 0.91
The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma. Pathology (2008) 0.90
Ziv-aflibercept in metastatic colorectal cancer. Biologics (2013) 0.88
αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation. Breast Cancer Res Treat (2013) 0.85
High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells. Int J Cancer (2012) 0.83
SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer. PLoS One (2014) 0.82
Pseudophosphorylated αB-crystallin is a nuclear chaperone imported into the nucleus with help of the SMN complex. PLoS One (2013) 0.81
Is alpha-B crystallin an independent marker for prognosis in lung cancer? Heart Lung Circ (2013) 0.79
Molecular mechanisms of α-crystallinopathy and its therapeutic strategy. Biol Pharm Bull (2011) 0.79
Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. Int J Cancer (2008) 0.79
Alpha-crystallins and tumorigenesis. Curr Mol Med (2012) 0.78
Alpha B-crystallin - a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavity. Acta Otolaryngol (2014) 0.77